靜脈通路裝置市場規模、佔有率和成長分析(按產品、應用和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1914095

靜脈通路裝置市場規模、佔有率和成長分析(按產品、應用和地區分類)-2026-2033年產業預測

Vascular Access Device Market Size, Share, and Growth Analysis, By Product (Short Peripheral Intravenous Catheter, Huber Needles), By End Use (Hospitals, Ambulatory care centers), By Region - Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 195 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球靜脈通路裝置市場規模預計在 2024 年達到 92.8 億美元,從 2025 年的 97.8 億美元成長到 2033 年的 148.9 億美元,在預測期(2026-2033 年)內複合年成長率為 5.4%。

全球靜脈通路裝置市場的主要驅動力是癌症、糖尿病、腎臟病和心血管疾病等慢性病的日益增多。這些疾病需要長期治療,例如化療和透析。人口老化和生活方式的改變導致慢性病發病率上升,進而推動了對耐用靜脈通路裝置的需求。隨著醫療機構採用先進的解決方案以實現有效治療,這一趨勢正在促進市場成長。此外,不斷湧現的技術創新正在重塑市場格局,製造商正在開發抗菌塗層導管和微創系統等新一代產品。這些進步有助於減少併發症、提高病患舒適度並降低再入院率,從而符合高品質醫療和病人安全的理念。這正在加速全球對先進靜脈通路裝置的採用。

全球靜脈通路裝置市場促進因素

癌症、腎臟病和心血管疾病等慢性疾病的日益普及是推動全球靜脈通路裝置市場擴張的關鍵因素。這些疾病需要長期治療,例如化療、透析和靜脈輸液。隨著患者群體的不斷擴大,醫療專業人員越來越傾向於使用創新靜脈通路裝置,以提供有效的治療、提高患者安全並最大限度地減少手術併發症。這一趨勢反映了人們對能夠應對慢性疾病管理複雜性的可靠醫療解決方案日益成長的需求,並凸顯了靜脈通路裝置在現代醫療保健中的關鍵作用。

限制全球靜脈通路裝置市場的因素

全球靜脈通路裝置市場面臨許多限制因素,包括感染疾病、血栓症和導管功能障礙等併發症,即便在設計創新方面不斷改進,這些問題仍然可能發生。這些問題常常引發醫療服務提供者對病人安全的擔憂,以及對操作人員技能水準的質疑。此外,潛在的法律責任風險進一步加劇了這些擔憂,導致醫療服務提供者在全面推廣這些裝置時猶豫不決。因此,這種猶豫不決影響了市場擴張,並凸顯了持續培訓和改善裝置安全性對於增強醫療服務提供者信心和改善患者預後至關重要。

全球靜脈通路裝置市場趨勢

全球靜脈通路裝置市場正呈現出向門診和居家醫療服務顯著發展的趨勢,這主要得益於人們對便利、經濟的醫療解決方案日益成長的需求。隨著醫療系統越來越注重以病人為中心的護理,攜帶式、易用的靜脈通路裝置的應用也日益普及。這些創新裝置使患者能夠在舒適的家中接受靜脈輸液、透析和營養支持等必要治療,從而最大限度地減少住院次數和相關醫療費用。這種轉變不僅提升了患者的便利性,也加速了血管通路技術在全球的應用,為更便利的醫療保健鋪平了道路。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析

全球靜脈通路裝置市場規模(依產品及複合年成長率分類)(2026-2033 年)

  • 短期周邊靜脈導管
    • 安全
    • 標準/傳統
  • 胡伯針
    • 安全
    • 標準/傳統
  • 中線導管
    • 標準
    • 高壓注入
  • 周邊置入的中央靜脈導管(PICC)
    • 標準
    • 高壓注入
  • 中央靜脈導管(CVC)
    • 急性期
    • 隧道類型
  • 透析導管
    • 急性期
    • 隧道類型
  • 凹陷端口
    • 單腔
    • 雙腔型

全球靜脈通路裝置市場規模(按最終用途和複合年成長率分類)(2026-2033 年)

  • 醫院
  • 門診治療中心
  • 其他最終用戶

全球靜脈通路裝置市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Becton, Dickinson and Company(BD)(US)
  • Teleflex Incorporated(US)
  • B. Braun SE(Germany)
  • ICU Medical, Inc.(US)
  • Medtronic plc(Ireland)
  • AngioDynamics, Inc.(US)
  • Terumo Corporation(Japan)
  • Cook Medical(US)
  • Baxter International Inc.(US)
  • Fresenius Medical Care(Germany)
  • NIPRO Medical Corporation(Japan)
  • Vygon SA(France)
  • Merit Medical Systems, Inc.(US)
  • Siemens Healthineers(Germany)
  • Edwards Lifesciences Corporation(US)
  • PRODIMED(France)
  • 3M Company(US)
  • Access Vascular, Inc.(US)
  • Medical Components, Inc.(US)
  • AMECATH(Egypt)

結論與建議

簡介目錄
Product Code: SQMIG35A3156

Global Vascular Access Device Market size was valued at USD 9.28 Billion in 2024 and is poised to grow from USD 9.78 Billion in 2025 to USD 14.89 Billion by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).

The Global Vascular Access Device Market is primarily driven by the increasing prevalence of chronic diseases such as cancer, diabetes, kidney disorders, and cardiovascular issues, which necessitate long-term treatment solutions like chemotherapy or dialysis. As populations age and lifestyles contribute to rising chronic illness rates, the demand for durable vascular access devices is intensifying. This trend propels market growth as healthcare providers adopt advanced solutions for effective treatment. Additionally, ongoing technological innovations are reshaping the market, with manufacturers developing next-generation products like antimicrobial-coated catheters and minimally invasive systems. These advancements mitigate complications, enhance patient comfort, and reduce hospital readmission rates, aligning with the focus on quality care and patient safety, thereby accelerating the adoption of sophisticated vascular access devices globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vascular Access Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vascular Access Device Market Segments Analysis

Global Vascular Access Device Market is segmented by Product, End Use and region. Based on Product, the market is segmented into Short Peripheral Intravenous Catheter, Huber Needles, Midline Catheters, Peripherally Inserted Central Catheter (PICCs), Central Venous Catheter (CVCs), Dialysis Catheters and Implantable Ports. Based on End Use, the market is segmented into Hospitals, Ambulatory care centers and Other end use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vascular Access Device Market

The rise in prevalence of chronic diseases like cancer, kidney disorders, and cardiovascular issues is a significant factor propelling the expansion of the global vascular access device market. These illnesses necessitate prolonged treatment options such as chemotherapy, dialysis, and intravenous therapies. As the patient population expands, healthcare professionals are increasingly turning to innovative vascular access devices to facilitate effective treatment delivery, enhance patient safety, and minimize complications during procedures. This trend reflects a growing demand for reliable medical solutions that cater to the complexities of managing chronic health conditions and underscores the vital role of vascular access devices in contemporary healthcare.

Restraints in the Global Vascular Access Device Market

The Global Vascular Access Device market faces significant restraints due to various complications that can arise despite innovations in design, including infections, thrombosis, and catheter malfunctions. These issues often lead to apprehension among healthcare providers regarding patient safety and the requirement for skilled professionals to perform insertions. Moreover, the potential for legal liabilities further exacerbates these concerns, resulting in a reluctance to fully embrace these devices. Consequently, such hesitations impact market expansion and highlight the critical need for ongoing training and enhancements in device safety to foster confidence among healthcare practitioners and improve patient outcomes.

Market Trends of the Global Vascular Access Device Market

The Global Vascular Access Device market is witnessing a significant trend toward outpatient and home healthcare services, propelled by a rising demand for convenient and cost-effective medical solutions. As healthcare systems increasingly prioritize patient-centric care, the adoption of portable and user-friendly vascular access devices is on the rise. These innovations facilitate essential treatments such as intravenous therapies, dialysis, and nutritional support within the comfort of patients' homes, thereby minimizing hospital visits and associated healthcare costs. This shift not only enhances patient convenience but also drives the broader acceptance of vascular access technologies worldwide, paving the way for a more accessible healthcare landscape.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Vascular Access Device Market Size by Product & CAGR (2026-2033)

  • Market Overview
  • Short Peripheral Intravenous Catheter
    • Safety
    • Standard/ Conventional
  • Huber Needles
    • Safety
    • Standard/ Conventional
  • Midline Catheters
    • Standard
    • Power-Injectable
  • Peripherally Inserted Central Catheter (PICCs)
    • Standard
    • Power-Injectable
  • Central Venous Catheter (CVCs)
    • Acute
    • Tunneled
  • Dialysis Catheters
    • Acute
    • Tunneled
  • Implantable Ports
    • Single-Lumen
    • Dual-Lumen

Global Vascular Access Device Market Size by End Use & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Ambulatory care centers
  • Other end use

Global Vascular Access Device Market Size & CAGR (2026-2033)

  • North America (Product, End Use)
    • US
    • Canada
  • Europe (Product, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Becton, Dickinson and Company (BD) (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Teleflex Incorporated (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun SE (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICU Medical, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AngioDynamics, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Medical Care (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • NIPRO Medical Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vygon SA (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merit Medical Systems, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Edwards Lifesciences Corporation (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PRODIMED (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 3M Company (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Access Vascular, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medical Components, Inc. (U.S.)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AMECATH (Egypt)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations